Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors

Immunotherapies based on immune checkpoint blockade have shown remarkable clinical outcomes and durable responses in patients with many tumor types. Nevertheless, these therapies lack efficacy in most cancer patients, even causing severe adverse events in a small subset of patients, such as inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco, Ester, Chocarro, Luisa, Fernández-Rubio, Leticia, Bocanegra, Ana, Arasanz, Hugo, Echaide, Miriam, Garnica, Maider, Piñeiro-Hermida, Sergio, Kochan, Grazyna, Escors, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917067/
https://www.ncbi.nlm.nih.gov/pubmed/36768997
http://dx.doi.org/10.3390/ijms24032676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917067/
https://www.ncbi.nlm.nih.gov/pubmed/36768997
http://dx.doi.org/10.3390/ijms24032676

Ejemplares similares